Human papillomavirus testing, vaccination, and gynecologic screening: Fight or flight?

American Journal of Clinical Pathology

Volumn 128, Issue 5, 2007, Pages 726-728

  Covell, Jamie L ^a   Stoler, Mark H ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

CANCER SCREENING; COLPOSCOPY; EDITORIAL; GYNECOLOGICAL EXAMINATION; HEALTH PROGRAM; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 6; PAPANICOLAOU TEST; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; UTERINE CERVIX CANCER; VACCINATION; VIRUS IDENTIFICATION; VIRUS INFECTION; WART VIRUS;

ADOLESCENT; ADULT; FEMALE; GUIDELINES AS TOPIC; HEALTH PLANNING GUIDELINES; HUMANS; MASS SCREENING; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 36248993475     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/D4VHPHBLQCQ9G0UX     Document Type: Editorial

References (11)

1. Solomon D, Breen N, McNeel T. Cervical cancer screening rates in the United States and the potential impact of implementation of screening guidelines. CA Cancer J Clin. 2007;57:105-111.
2. Eltoum IA, Roberson J. Impact of HPV testing, HPV vaccine development and changing screening frequency on national Pap test volume. Cancer. 2007;111:34-40.
3. Cuzick J, Mayrand MH, Ronco G, et al. Chapter 10: new dimensions in cervical cancer screening. Vaccine. 2006;24(suppl 3):S90-S97.
4. Elliott VS. Dr Pap's smear: the test and its times. Am Med News. September 3, 2007.
5. Moriarity AT. A rock and a hard place: HPV testing and financial gain. Diagn Cytopathol. 2007;35:463-464.
6. Schiffman M. Integration of human papillomavirus vaccination, cytology, and human papillomavirus testing. Cancer. 2007;111:145-153.
7. Clifford G, Franceschi, Diaz M, et al. Chapter 3: HPV-type distribution in women with and without cervical neoplastic diseases. Vaccine. 2006;24(suppl 3):S26-S34.
8. Frable WJ. Screening for cervical cancer: controversy and contention or thoughtful analysis [editorial]. Cancer. 2007;111:143-144.
9. Bosch FX. Preface. Vaccine. 2006;24(suppl 3):v-vi.
10. Eltoum IA, Roberson J. Impact of expected changes in national Papanicolaou test volume on the cytotechnology labor market: an impending crisis. Am J Clin Pathol. 2007;128:665-670.
11. Bugbee AC. ASCP Board of Registry's 2006 annual survey of medical laboratory science programs. Lab Med. 2007;38:463-471.